A novel experimental treatment for equine herpesvirus type-1 (EHV-1) called RNA interference shows promise, but more research is needed before this technology becomes commercially available. EHV-1 evades the horse’s immune system during infection and can lie dormant in the horse’s body. For these reasons, making an effective vaccine against EHV-1 has been, and continues to be, a challenge. Continue reading…
Discover more from Ebarrelracing.com
Subscribe to get the latest posts sent to your email.




